Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology, CNS Agents May Dominate 2006 NME Approvals; 2005 Total Is 18

Related Content

Pfizer Parecoxib, Oporia Setbacks Reflect Tougher FDA Stance, CEO Says

Oct 24 2005

Aventis, Genta To Meet With FDA After Genasense NDA Withdrawal

May 24 2004

Drug Approvals Will Be Down “Significantly” In ’05, FDA’s Gottlieb Predicts

Dec 12 2005

Insmed Growth Agent iPlex Joins Tercica’s Increlex With Orphan Exclusivity

Dec 19 2005

GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?

Sep 26 2005

Bayer/Onyx Nexavar Approved For Broad Advanced Kidney Cancer Indication

Jan 02 2006

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window